Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)

NCT02526160 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

X-linked Hypophosphatemia

Interventions

BIOLOGICAL: burosumab
OTHER: Placebo

Sponsor

Kyowa Kirin, Inc.

Collaborators

[object Object]